BGAI
HRMY icon

Bruce G. Allen Investments’s Harmony Biosciences HRMY Stock Holding History

Bruce G. Allen Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$112 – 1073
2026
Q1 		$112 Sell
4
-11
-73% -$361 ﹤0.01% 1078
2025
Q4 		$561 Hold
15
– – ﹤0.01% 952
2025
Q3 		$413 Buy
15
+3
+25% +$103 ﹤0.01% 994
2025
Q2 		$379 Buy
+12
New +$386 ﹤0.01% 1001

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bruce G. Allen Investments's HRMY Position: Q2 2026 in Review

Bruce G. Allen Investments sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 4 shares — an estimated $112 sold.

Bruce G. Allen Investments first reported a position in HRMY in Q2 2025 and held it in 4 quarters. The position peaked at $561 in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Bruce G. Allen Investments reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Bruce G. Allen Investments sold 4 Harmony Biosciences shares in Q2 2026, an estimated $112.
  • Bruce G. Allen Investments first reported a position in Harmony Biosciences in Q2 2025 and held it in 4 quarters.
  • Bruce G. Allen Investments's Harmony Biosciences position peaked at $561 in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.